CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
CLOVER HEALTH INVESTMENTS, CORP. /DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$4.44−0.04 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $2.42B
- P/E (TTM)
- –
- Dividend yield
- –
CLOVER HEALTH INVESTMENTS, CORP. /DE income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -0.7%
- Net margin
- -0.7%
- Return on equity, FY2025
- -26.3%
Financial strength
- Current ratio
- 1.50
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 61.5%
Valuation
- P/E ratio
- –
- Price to sales
- 0.98
- Price to book
- 6.44
- Dividend yield
- –